These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904 [TBL] [Abstract][Full Text] [Related]
27. Fluvastatin is effective against thymic carcinoma. Hayashi K; Nakazato Y; Morito N; Sagi M; Fujita T; Anzai N; Chida M Life Sci; 2020 Jan; 240():117110. PubMed ID: 31786191 [TBL] [Abstract][Full Text] [Related]
28. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins. Yu R; Longo J; van Leeuwen JE; Mullen PJ; Ba-Alawi W; Haibe-Kains B; Penn LZ Cancer Res; 2018 Mar; 78(5):1347-1357. PubMed ID: 29229608 [TBL] [Abstract][Full Text] [Related]
29. Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation. Stokes ME; Small JC; Vasciaveo A; Shimada K; Hirschhorn T; Califano A; Stockwell BR Sci Rep; 2020 Jul; 10(1):10748. PubMed ID: 32612149 [TBL] [Abstract][Full Text] [Related]
30. Mevalonate Pathway and Human Cancers. Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953 [TBL] [Abstract][Full Text] [Related]
31. Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins. van Leeuwen JE; Ba-Alawi W; Branchard E; Cruickshank J; Schormann W; Longo J; Silvester J; Gross PL; Andrews DW; Cescon DW; Haibe-Kains B; Penn LZ; Gendoo DMA Nat Commun; 2022 Oct; 13(1):6323. PubMed ID: 36280687 [TBL] [Abstract][Full Text] [Related]
32. Dysregulation of the mevalonate pathway promotes transformation. Clendening JW; Pandyra A; Boutros PC; El Ghamrasni S; Khosravi F; Trentin GA; Martirosyan A; Hakem A; Hakem R; Jurisica I; Penn LZ Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15051-6. PubMed ID: 20696928 [TBL] [Abstract][Full Text] [Related]
33. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells. Casella C; Miller DH; Lynch K; Brodsky AS Gynecol Oncol; 2014 Nov; 135(2):333-41. PubMed ID: 25134999 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of Orbivirus Replication by Fluvastatin and Identification of the Key Elements of the Mevalonate Pathway Involved. Mohd Jaafar F; Monsion B; Belhouchet M; Mertens PPC; Attoui H Viruses; 2021 Jul; 13(8):. PubMed ID: 34452303 [TBL] [Abstract][Full Text] [Related]
35. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651 [TBL] [Abstract][Full Text] [Related]
36. The importance of LDL and cholesterol metabolism for prostate epithelial cell growth. Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL PLoS One; 2012; 7(6):e39445. PubMed ID: 22761797 [TBL] [Abstract][Full Text] [Related]
37. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress. Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820 [TBL] [Abstract][Full Text] [Related]
38. Enhanced Liver Regeneration After Partial Hepatectomy in Sterol Regulatory Element-Binding Protein (SREBP)-1c-Null Mice is Associated with Increased Hepatocellular Cholesterol Availability. Peng J; Yu J; Xu H; Kang C; Shaul PW; Guan Y; Zhang X; Su W Cell Physiol Biochem; 2018; 47(2):784-799. PubMed ID: 29807364 [TBL] [Abstract][Full Text] [Related]
39. SREBP‑2 expression pattern contributes to susceptibility of Mongolian gerbils to hypercholesterolemia. Li C; Guo H; Dai F; Huo X; Li Z; Zhang S; Fu R; He Z; Gu M; Du X; Chen Z Mol Med Rep; 2018 Feb; 17(2):3288-3296. PubMed ID: 29257228 [TBL] [Abstract][Full Text] [Related]
40. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Sever N; Yang T; Brown MS; Goldstein JL; DeBose-Boyd RA Mol Cell; 2003 Jan; 11(1):25-33. PubMed ID: 12535518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]